TITLE

Survival after resection of synchronous bilateral lung cancer

AUTHOR(S)
De Leyn, Paul; Moons, Johnny; Vansteenkiste, Johan; Verbeken, Eric; Van Raemdonck, Dirk; Nafteux, Philippe; Decaluwe, Herbert; Lerut, Tony
PUB. DATE
December 2008
SOURCE
European Journal of Cardio-Thoracic Surgery;Dec2008, Vol. 34 Issue 6, p1215
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Abstract: Objective: Due to recent advances in imaging, the incidence of patients presenting with bilateral lung lesions is increasing. A single contralateral lung lesion can be an isolated metastasis or a synchronous second primary lung cancer. For the revision of the TNM in 2009, the International Association for the Study of Lung Cancer Staging Committee proposes that patients with contralateral lung nodules remain classified as M1 disease. In this retrospective study, the survival after resection of synchronous bilateral lung cancer is evaluated. Methods: From our database of bronchial carcinoma, all patients with bilateral synchronous lung lesions between 1990 and 2007 were retrieved. We analysed 57 patients in which, after functional assessment and thorough staging, the decision was taken to treat the disease with bilateral resection. All these files were retrospectively reviewed. Twenty-one patients were excluded from this analysis because only one side was resected (n =15) or one of the lesions was non-neoplastic on final pathology (n =6). Results: Thirty-six patients underwent bilateral resection for synchronous multiple primary lung cancer. All resections were performed as sequential procedures. In 23 patients, one side was anatomically resected (2 pneumonectomies) and the contralateral side was resected by limited resection. In 10 patients a bilateral lobectomy was performed, and 3 patients had bilateral limited resections. Postoperative mortality was 2.8%. Eighteen patients had a tumour with a different histological pattern, confirmed by comparing both specimens by an experienced senior pathologist. The median survival after resection of synchronous bilateral lung cancer in our series was 25.4 months with a 5-year survival rate of 38%. There was no significant difference in survival between patients with different versus same histology. This survival is much higher compared to the survival of assumed stage IV disease. Conclusions: Our study shows that selected patients with bilateral lung cancer may benefit from an aggressive approach, with acceptable morbidity and mortality, and rewarding long-term survival. Patients with a single contralateral lung lesion should not be treated as disseminated disease (stage IV). After extensive searching for metastatic spread, bilateral surgical resection should be considered in fit patients.
ACCESSION #
35327846

 

Related Articles

  • The impact of the type of resection on survival in patients with N1 non-small-cell lung cancers Aydogmus, Umit; Cansever, Levent; Sonmezoglu, Yasar; Karapinar, Kemal; Kocaturk, Celalettin Ibrahim; Bedirhan, Mehmet Ali // European Journal of Cardio-Thoracic Surgery;Feb2010, Vol. 37 Issue 2, p446 

    Abstract: Objective: Complete resection is the therapy of choice in non-small-cell lung cancer (NSCLC). There is no agreement on the type of resection, especially when interlobar N1 disease is present. The present study explored the effect of the type of resection on survival in the presence of...

  • The $150 Therapeutic Pocket Ultrasound. Valenza, T. // Imaging Economics;Aug2009, Vol. 22 Issue 7, p21 

    The article focuses on the effort of George K. Lewis, a member of the Presidential and National Science Foundation at Cornell Biomedical Engineering, in developing methods that can be use in utlatrasound to enhance the penetration of drugs to malignant brain cell after a tumor resection....

  • Evaluation of video-assisted thoracoscopic surgery for pulmonary metastases: 11-years of experience. Saisho, Shinsuke; Nakata, Masao; Sawada, Shigeki; Yamashita, Motohiro; Saeki, Hideyuki; Kurita, Akira; Takashima, Shigemitsu // Surgical Endoscopy;Jan2009, Vol. 23 Issue 1, p55 

    Although video-assisted thoracoscopic surgery (VATS) has been applied to pulmonary resection for pulmonary metastases, the clinical validity of this approach remains controversial. The purpose of this study was to evaluate the validity and problems of VATS for pulmonary metastasectomy. From...

  • Prognostic factors and long-term results of pulmonary metastasectomy for pediatric histologies. Tronc, François; Conter, Cécile; Marec-Berard, Perrine; Bossard, Nadine; Remontet, Laurent; Orsini, Alessandro; Gamondes, Jean-Paul; Louis, Dominique // European Journal of Cardio-Thoracic Surgery;Dec2008, Vol. 34 Issue 6, p1240 

    Abstract: Objective: Pulmonary resection in metastatic pediatric solid tumors is an accepted method of treatment. The purpose of this study was to determine the clinical course, outcome and prognostic factors after surgery. Methods: A retrospective analysis from 1985 to 2006 of 52 patients less...

  • ISOLATED LUNG CHEMOPERFUSION FOR METASTASES OF SOLID TUMORS. Levchenko, E. V.; Senchik, K. Ju.; Barchuk, A. S.; Lemekhov, V. G.; Timofeeva, E. S.; Dunaevskiy, I. V.; Gelfond, V. M.; Gorokhov, L. V.; Arseniev, A. I.; Radjabova, Z. A.; Ergnyan, S. M.; Dolgopolskiy, M. N.; Moiseenko, V. M. // Oncosurgery / Onkohirurgia;2012, Vol. 4 Issue 3, p46 

    In the period from February 2007 to May 2011, 50 normothermic (37oC) isolated lung chemoperfusions (ILCP) with metastasectomy were performed in 37 patients with isolated lung metastases (soft tissue sarcoma -- 9, osteosarcoma -- 3, chondrosarcoma -- 2, melanoma of skin -- 2, uterine sarcoma --...

  • Scientific Basis and Clinical Application of ICG Fluorescence Imaging: Hepatobiliary Cancer. Ishizawa, Takeaki; Harada, Nobuhiro; Muraoka, Arata; Aoki, Taku; Beck, Yoshifumi; Hasegawa, Kiyoshi; Ijichi, Masayoshi; Kusaka, Koji; Shibasaki, Masayuki; Bandai, Yasutsugu; Kokudo, Norihiro // Open Surgical Oncology Journal;2010 Special Issue, p31 

    Despite recent advances in imaging modalities, the intraoperative diagnosis of small liver cancers remains unsatisfactory. Although fluorescent imaging using indocyanine green (ICG) has just been applied to hepatobiliary surgeries, this technique has the potential to delineate small liver...

  • A clinical "near miss" highlights risk management issues surrounding ultrasound-guided and wire-localised breast resections. Leff, Daniel Richard; Vincent, Charles; Al-Mufti, Ragheed; Cunningham, Deborah; Darzi, Ara; Hadjiminas, Dimitri J. // Patient Safety in Surgery;2012, Vol. 6 Issue 1, p15 

    Background: The introduction of the National Health Service (NHS) Breast Screening Programme has led to a considerable increase in the detection of impalpable breast cancer. Patients with impalpable breast cancer typically undergo oncological resection facilitated either by the insertion of...

  • Staging the Axilla with selective sentinel node biopsy in patients with previous excision of non-palpable and palpable breast cancer. Ruano, R.; Ramos, M.; Garcia-Talavera, J.; Serrano, E.; Arriba, A.; Gonzalez-Orus, J.; Iglesias, M.; Macias, M. // European Journal of Nuclear Medicine & Molecular Imaging;Jul2008, Vol. 35 Issue 7, p1299 

    To present our experience in the therapeutic approach of the sentinel node biopsy (SNB) in patients with previous excision of the breast cancer, divided in non-palpable and palpable lesions, in comparison with time treatment and stagement of breast cancer. In the period 2001–2006, 138...

  • Design and Endpoints of Clinical and Translational Trials in Advanced Colorectal Cancer. A Proposal from GROUP Espa�ol Multidisciplinar en Cancer Digestivo (GEMCAD). Carrera, Gemma; Garcia-Albeniz, Xabier; Ayuso, Juan Ram�n; Aparicio, Jorge; Castells, Antoni; Codony-Servat, Jordi; Feliu, Jaime; Fuster, David; Gallego, Rosa; Pag�s, Mario; Torres, Ferran; Maurel, Joan // Reviews on Recent Clinical Trials;May2011, Vol. 6 Issue 2, p158 

    Meta-analytic reviews of Randomized Clinical Trials (RCT) have reached contradictory conclusions regarding the benefit of medical interventions in Advanced Colorectal Cancer (ACRC). Surrogate markers of survival benefit, such as response rate (RR) and progression free-survival (PFS) often show...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics